NeoGenomics, Inc. (NEO)

NASDAQ

$16.59

$+0.19

(+1.16%)

Previous Close: ⁦$16.39⁩

Market Closed

NeoGenomics, Inc. (NEO) Live Price Chart

Last updated: ⁦2026-10-24 08:13:20⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

NeoGenomics, Inc. (NEO) operates in the SERVICES-TESTING LABORATORIES sector and is listed on NASDAQ. The stock is currently priced at $16.59, with a market capitalization of $2.11B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $7.07 to $20.15. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$2.11B
Open	$16.36
Day's High	$61.57
Day's Low	$2.05
Previous Close	$16.39
Volume	1.12M
Average Volume	2.18M
P/E Ratio	--
52-Week High	$20.15
52-Week Low	$7.07
Dividend Yield	--
Earnings Date	--

NeoGenomics, Inc. (NEO) Latest Closing Stock Price

NeoGenomics, Inc. (NEO) last closed at $16.39 as of 2026-10-24 00:00:00, unchanged from the previous close of $16.39.

During the latest regular trading session, NEO traded between $2.05 and $61.57, with a volume of 1.12M shares. The closing price was near the lower end and near the upper end of its 52-week range.

NeoGenomics, Inc. (NEO) 7-Day Stock Price Change

Over the past seven days, NeoGenomics, Inc. (NEO) moved from $17.25 to $16.59, representing a decline of 3.83% ($0.66).

The stock traded between $15.86 and $17.45 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.

The average daily volume was 1.64 million shares, down versus the previous seven-day period, indicating lower trading activity.

NEO 52-Week Price Position

Position in Range: 72.8%

52W Low$7.07

52W High$20.15

NEO is currently trading at $16.59, placing it 72.8% of the way from its 52-week low of $7.07 to its 52-week high of $20.15. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is NeoGenomics, Inc. (NEO)?

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

NeoGenomics, Inc. Information

Industry	SERVICES-TESTING LABORATORIES
Employees	2500
Exchange	NASDAQ
Company Website	https://www.neogenomics.com

How to Buy NeoGenomics, Inc. (NEO) Stock on MEXC

Eligible investors can buy real shares of NeoGenomics, Inc. (NEO) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for NEO and Place Your Order

Open the RealStocks trading page and search for NEO. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is NeoGenomics, Inc. (NEO) stock price today?

NeoGenomics, Inc. (NEO) is currently trading at $ 16.59, up 1.21% ($0.20) from the previous close of $ 16.39. Intraday prices update in real time during regular trading hours.

2.Is NEO stock going up or down today?

As of 2026-10-24 00:00:00, NEO is trading at $ 16.59, up 1.21% ($0.20) from its previous close of $ 16.39. The stock has traded between $ 2.05 and $ 61.57 during today’s regular session. Past price movements do not guarantee future results.

3.What is NEO pre-market price?

As of 2026-10-24 00:00:00, NEO is trading at $ 15.93 in pre-market trading, down 2.84% ($0.46) from the previous close of $ 16.39. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is NEO after-hours price?

As of 2026-10-24 00:00:00, NEO is trading at $ 16.59 in after-hours trading, up 1.19% ($0.20) from the regular-session close of $ 16.39. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is NEO stock trading now?

NEO trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does NEO sit relative to its 52-week high and low?

Over the past 52 weeks, NEO has traded between a low of $ 7.07 and a high of $ 20.15. At $ 16.59, the stock is positioned 72.8% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is NeoGenomics, Inc. in?

NeoGenomics, Inc. (NEO) operates in the SERVICES-TESTING LABORATORIES sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is NeoGenomics, Inc.'s market capitalization and where is it listed?

NeoGenomics, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 2.11B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is NEO valued in terms of P/E ratio and EPS?

NEO trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.40. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does NeoGenomics, Inc. pay a dividend?

NeoGenomics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.